Surrozen, Inc./DE (SRZN) stock

SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30

$31.61−0.06 (-0.19%)

Close on Nov 13, 2026Market cap $371.53MP/E –Yield –

Surrozen statistics

73 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 22, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $371.53M; $272.32M
Enterprise Value: $269.49M; $146.23M
PS Ratio: 32.28; 3.66

Enterprise valuationIndustry

EV / Sales: 23.41; 2.57

Share statisticsIndustry

Shares Outstanding: 12M; 58M
Shares Change (YoY): 171.0%; 10.8%
Shares Change (QoQ): 2.30%; 0.50%
Float: 7M; 49M
Shares Held by Insiders: 44.5%; 11.7%
Shares Held by Institutions: 91.3%; 56.4%

Short sellingIndustry

Short Interest: 3M; –
Short Interest Change: 3.31%; -0.80%
Short % of Float: 49.6%; 9.01%
Short % of Shares Outstanding: 27.5%; 6.30%
Days to Cover: 8.51; 5.15

Stock price statisticsIndustry

52-Week High: $37.83; –
52-Week Low: $12.12; –
20-Day Moving Average: $29.09; –
50-Day Moving Average: $25.90; –
200-Day Moving Average: $25.63; –
Average True Range (14): $2.42; –
Price Change (1 Week): 1.97%; -1.15%
Price Change (1 Month): 26.1%; -4.87%
Price Change (3 Months): 32.9%; -21.0%
Price Change (6 Months): 12.3%; -20.6%
Price Change (YTD): 39.9%; -23.6%
Price Change (1 Year): 144.3%; -22.4%
Price Change (3 Years): 485.4%; -29.5%
Price Change (5 Years): -77.7%; -77.9%
Average Volume (10 Days): 158,541; –
Average Volume (20 Days): 279,390; –
Average Volume (90 Days): 455,199; –
Relative Volume: 0.23; 0.70
Relative Strength Index (14): 59.5; 43.4
Volatility (1 Year): 135.5%; 80.1%
Beta (5 Years): 0.52; 1.07

MarginsIndustry

Operating Margin: -385.3%; -38.7%
Profit Margin: -2885.3%; -31.6%
EBITDA Margin: -383.4%; -27.7%
FCF Margin: -303.9%; -9.56%

Returns on capitalIndustry

Return on Assets (ROA): -304.3%; -40.6%
Return on Capital Employed (ROCE): -41.6%; -37.9%

Financial positionIndustry

Current Ratio: 12.14; 3.30
Quick Ratio: 11.88; 2.39

GrowthIndustry

Revenue Growth (YoY): -8.79%; 6.82%
Revenue Growth (3Y CAGR): -34.7%; 2.25%

EfficiencyIndustry

Asset Turnover: 0.11; 0.40
Revenue Per Employee: $261.61K; $429.29K
Profits Per Employee: -$7.55M; -$689.41K
Employee Count: 44; 74
WACC: 7.71%; 10.2%

Income statement (TTM)Industry

Revenue: $11.51M; $66.37M
Operating Income: -$44.35M; -$21.37M
Net Income: -$332.13M; -$22.35M
EBITDA: -$44.13M; -$17.21M

Balance sheetIndustry

Cash & Short-Term Investments: $102.04M; $68.68M
Net Cash (Debt): $102.04M; $17.76M
Net Cash Per Share: $8.68; $0.80
Equity (Book Value): -$218.67M; $53.89M
Book Value Per Share: -$18.60; $1.50
Tangible Book Value: -$218.67M; $27.13M
Working Capital: $100.39M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$34.76M; -$12.38M
Capital Expenditures: -$222.00K; -$1.00M
Free Cash Flow: -$34.98M; -$18.21M
FCF Per Share: -$2.98; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -89.4%; -21.8%
FCF Yield: -9.42%; -9.44%
Buyback Yield: -0.94%; -0.76%
Shareholder Yield: -0.94%; 0.00%

Taxes and interestIndustry

Income Tax: $0; $73.00K

Scores and fair valueIndustry

Altman Z-Score: -6.78; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	SRZN	S&P 500	Difference	SRZN per year	S&P 500 per year
1 month	+34.5%	-3.0%	+37.5 pts
3 months	+33.2%	-2.8%	+36.0 pts
Year to date	+39.9%	+11.5%	+28.4 pts
1 year	+160.8%	+13.5%	+147.3 pts
3 years	+485.4%	+77.7%	+407.7 pts	+80.2%	+21.1%
5 years	-77.7%	+72.6%	−150.4 pts	-26.0%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M SRZN shares were sold short on Oct 30, 2026, up 3.3% from the previous report, or 49.58% of the shares available to trade. At recent volumes it would take 8.5 days to buy them back. Over the last 20 sessions, 41.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	3,234,984	+3.3%	379,990	8.5
Oct 15, 2026	3,131,276	+43.0%	656,838	4.8
Sep 30, 2026	2,189,760	-0.3%	1,450,761	1.5
Sep 15, 2026	2,195,505	+51.9%	173,121	12.7
Aug 31, 2026	1,445,491	+15.3%	187,095	7.7
Aug 14, 2026	1,253,140	+8.9%	258,969	4.8
Jul 31, 2026	1,150,387	+18.5%	283,082	4.1
Jul 15, 2026	970,957	+36.8%	155,834	6.2
Jun 30, 2026	709,757	+105.1%	229,914	3.1
Jun 15, 2026	346,034	-37.3%	97,035	3.6
May 29, 2026	551,841	+1.0%	101,544	5.4
May 15, 2026	546,224	-3.4%	85,109	6.4